0001209191-21-057937.txt : 20210928 0001209191-21-057937.hdr.sgml : 20210928 20210928164659 ACCESSION NUMBER: 0001209191-21-057937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210924 FILED AS OF DATE: 20210928 DATE AS OF CHANGE: 20210928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frohlich Tom CENTRAL INDEX KEY: 0001823925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 211287695 MAIL ADDRESS: STREET 1: C/O CHINOOK THERAPEUTICS U.S., INC. STREET 2: 1600 FAIRVIEW AVE. E. CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHINOOK THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 FAIRVIEW AVE E. CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-485-7051 MAIL ADDRESS: STREET 1: 1600 FAIRVIEW AVE E. CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH, INC. DATE OF NAME CHANGE: 20111107 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-24 0 0001435049 CHINOOK THERAPEUTICS, INC. KDNY 0001823925 Frohlich Tom C/O CHINOOK THERAPEUTICS, INC. 1600 FAIRVIEW AVE. E. SEATTLE WA 98102 0 1 0 0 Chief Operating Officer Common Stock 2021-09-24 4 M 0 20000 0.42 A 153398 D Employee Stock Option (right to buy) 0.42 2021-09-24 4 M 0 20000 0.00 D 2030-03-17 Common Stock 20000 78847 D The stock option vests as to 25% of the total shares on March 6, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Kirk Schumacher, Attorney-in-Fact 2021-09-28